Abnormal expression of FLI1 protein is an adverse prognostic factor in acute myeloid leukemia.

Friend leukemia virus integration 1 (FLI1), an Ets transcription factor family member, is linked to acute myelogenous leukemia (AML) by chromosomal events at the FLI1 locus, but the biologic impact of FLI1 expression on AML is unknown. FLI1 protein expression was measured in 511 newly diagnosed AML patients. Expression was similar in peripheral blood (PB) and BM and higher at diagnosis than at relapse (P = .02). Compared with normal CD34(+) cells, expression in AML was above or below normal in 32% and 5% of patients, respectively. Levels were negatively correlated with an antecedent hematologic disorder (P = .002) but not with age or cytogenetics. Mutated NPM1 (P = .0007) or FLT3-ITD (P < .02) had higher expression. FLI1 levels were negatively correlated with 10 of 195 proteins associated with proliferation and stromal interaction, and positively correlated (R > 0.3) with 19 others. The FLI1 level was not predictive of remission attainment, but patients with low or high FLI1 expression had shorter remission duration (22.6 and 40.3 vs 51.1 weeks, respectively; P = .01) and overall survival (45.2 and 35.4 vs 59.4 weeks, respectively; P = .03). High FLI1 levels were adverse in univariate and multivariate analysis. FLI1 expression is frequently abnormal and prognostically adverse in AML. FLI1 and/or its response genes may be therapeutically targetable to interfere with AML cell biology.

[1]  V. A. Flørenes,et al.  Fli-1 expression in malignant melanoma. , 2008, Histology and histopathology.

[2]  H. Beug,et al.  FLI-1 inhibits differentiation and induces proliferation of primary erythroblasts , 1999, Oncogene.

[3]  A. Bernstein,et al.  Identification and mapping of a common proviral integration site Fli-1 in erythroleukemia cells induced by Friend murine leukemia virus. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[4]  A. Iwama,et al.  Cooperative interaction between ETS1 and GFI1 transcription factors in the repression of Bax gene expression , 2007, Oncogene.

[5]  J. Ghysdael,et al.  Direct regulation of BCL‐2 by FLI‐1 is involved in the survival of FLI‐1‐transformed erythroblasts , 2002, The EMBO journal.

[6]  Y. Ben-David,et al.  The role of Fli-1 in normal cell function and malignant transformation , 2000, Oncogene.

[7]  D. Cervi,et al.  Direct transcriptional regulation of MDM2 by Fli-1 , 2005, Oncogene.

[8]  G. Gilkeson,et al.  The Transcription Factor Fli-1 Modulates Marginal Zone and Follicular B Cell Development in Mice1 , 2008, The Journal of Immunology.

[9]  D. Watson,et al.  Dysregulation of granulocyte, erythrocyte, and NK cell lineages in Fli-1 gene-targeted mice. , 2005, Blood.

[10]  A. Seth,et al.  ETS transcription factors and their emerging roles in human cancer. , 2005, European journal of cancer.

[11]  C. Hauser,et al.  Changes in the Expression of Many Ets Family Transcription Factors and of Potential Target Genes in Normal Mammary Tissue and Tumors* , 2004, Journal of Biological Chemistry.

[12]  I. Kola,et al.  Regulation of the human stress response gene GADD153 expression: role of ETS1 and FLI-1 gene products , 1999, Cell Death and Differentiation.

[13]  Ioanna G Maroulakou,et al.  Expression and function of Ets transcription factors in mammalian development: a regulatory network , 2000, Oncogene.

[14]  R Favier,et al.  Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia. , 2000, Immunity.

[15]  D. Watson,et al.  Hemorrhage, Impaired Hematopoiesis, and Lethality in Mouse Embryos Carrying a Targeted Disruption of the Fli1Transcription Factor , 2000, Molecular and Cellular Biology.

[16]  Gary D Bader,et al.  BIND--The Biomolecular Interaction Network Database. , 2001, Nucleic acids research.

[17]  Y. Asano,et al.  Phosphorylation of Fli1 at Threonine 312 by Protein Kinase C δ Promotes Its Interaction with p300/CREB-Binding Protein-Associated Factor and Subsequent Acetylation in Response to Transforming Growth Factor β , 2009, Molecular and Cellular Biology.

[18]  F. Carlotti,et al.  Bcl-xL Expression Correlates with Primary Macrophage Differentiation, Activation of Functional Competence, and Survival and Results from Synergistic Transcriptional Activation by Ets2 and PU.1* , 2001, The Journal of Biological Chemistry.

[19]  S. Kornblau,et al.  High levels of constitutive WAF1/Cip1 protein are associated with chemoresistance in acute myelogenous leukemia. , 1995, Clinical Cancer Research.

[20]  Gordon B Mills,et al.  Functional proteomic profiling of AML predicts response and survival. , 2009, Blood.

[21]  G. Mills,et al.  Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells , 2006, Molecular Cancer Therapeutics.

[22]  É. Mezey,et al.  Immunohistochemical signal amplification by catalyzed reporter deposition and its application in double immunostaining. , 1996, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[23]  F. Liu,et al.  Fli1 Acts at the Top of the Transcriptional Network Driving Blood and Endothelial Development , 2008, Current Biology.

[24]  J. Testa,et al.  The ERGB/Fli-1 gene: isolation and characterization of a new member of the family of human ETS transcription factors. , 1992, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[25]  V. Sementchenko,et al.  Ets target genes: past, present and future , 2000, Oncogene.

[26]  U. Ozbek,et al.  Quantification of The FLI1 Gene Expression By Real-Time Quantitative RT-PCR , 2003 .

[27]  A. Tamir,et al.  Fli-1, an Ets-Related Transcription Factor, Regulates Erythropoietin-Induced Erythroid Proliferation and Differentiation: Evidence for Direct Transcriptional Repression of the Rb Gene during Differentiation , 1999, Molecular and Cellular Biology.

[28]  C. Bloomfield,et al.  Expression analyses identify MLL as a prominent target of 11q23 amplification and support an etiologic role for MLL gain of function in myeloid malignancies. , 2004, Blood.

[29]  M. Abe,et al.  ETS‐1 converts endothelial cells to the angiogenic phenotype by inducing the expression of matrix metalloproteinases and integrin β3 , 1999, Journal of cellular physiology.

[30]  D. Barber,et al.  The inositol phosphatase SHIP-1 is negatively regulated by Fli-1 and its loss accelerates leukemogenesis. , 2010, Blood.

[31]  P. Kotsantis,et al.  Elk‐1 associates with FAK, regulates the expression of FAK and MAP kinases as well as apoptosis in HK‐2 cells , 2008, Journal of cellular physiology.

[32]  Jin He,et al.  Profile of Ets gene expression in human breast carcinoma , 2007, Cancer biology & therapy.

[33]  C. Morris,et al.  Identification of amplified genes in a patient with acute myeloid leukemia and double minute chromosomes. , 1999, Cancer genetics and cytogenetics.

[34]  The Importance of Biological Databases in Biological Discovery , 2006, Current protocols in bioinformatics.

[35]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[36]  J. Hamada,et al.  Functional roles of Fli‐1, a member of the Ets family of transcription factors, in human breast malignancy , 2007, Cancer science.

[37]  V. Findlay,et al.  ETS Transcription Factor Expression and Conversion During Prostate and Breast Cancer Progression , 2010 .

[38]  A. Bernstein,et al.  Erythroleukemia induction by Friend murine leukemia virus: insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1. , 1991, Genes & development.

[39]  Hiroshi Kawada,et al.  Defective Megakaryopoiesis and Abnormal Erythroid Development inFli-1 Gene-Targeted Mice , 2001, International journal of hematology.

[40]  Xianqun Fan,et al.  Putative tumor suppressor miR‐145 inhibits colon cancer cell growth by targeting oncogene friend leukemia virus integration 1 gene , 2011, Cancer.

[41]  Don Gilbert,et al.  Biomolecular Interaction Network Database , 2005, Briefings Bioinform..

[42]  S. Ikeda,et al.  Identification of functional elements in the bidirectional promoter of the mouse Nthl1 and Tsc2 genes. , 2000, Biochemical and biophysical research communications.

[43]  Nianxiang Zhang,et al.  Highly Phosphorylated FOXO3A Is An Adverse Prognostic Factor in Acute Myeloid Leukemia. , 2009 .

[44]  A. Bernstein,et al.  Generation of a novel Fli-1 protein by gene targeting leads to a defect in thymus development and a delay in Friend virus-induced erythroleukemia , 1996, Molecular and cellular biology.

[45]  W. Farrar,et al.  IL-6 induces expression of the Fli-1 proto-oncogene via STAT3. , 2002, Biochemical and biophysical research communications.

[46]  S. Knuutila,et al.  Amplified, lost, and fused genes in 11q23–25 amplicon in acute myeloid leukemia, an array‐CGH study , 2006, Genes, chromosomes & cancer.

[47]  D. Pearse,et al.  Angiotensin II increases the expression of the transcription factor ETS-1 in mesangial cells. , 2008, American journal of physiology. Renal physiology.

[48]  Xuming He,et al.  Non-parametric quantification of protein lysate arrays , 2007, Bioinform..

[49]  B. Wiese,et al.  Transcription factor Fli‐1 expression by bone marrow cells in chronic myeloproliferative disorders is independent of an underlying JAK2 (V617F) mutation , 2006, European journal of haematology.

[50]  Kevin R. Coombes,et al.  Variable slope normalization of reverse phase protein arrays , 2009, Bioinform..

[51]  D. Watson,et al.  Ets transcription factors cooperate with Sp1 to activate the human Tenascin-C promoter , 1999, Oncogene.

[52]  A. Seth,et al.  Transactivation of GATA-1 promoter with ETS1, ETS2 and ERGB/Hu-FLI-1 proteins: stabilization of the ETS1 protein binding on GATA-1 promoter sequences by monoclonal antibody. , 1993, Oncogene.